- Home
- AKRO vs VEON Comparison
AKRO vs VEON Comparison
Compare AKRO & VEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- VEON
- Stock Information
- Founded
- AKRO 2017
- VEON 1992
- Country
- AKRO United States
- VEON United Arab Emirates
- Employees
- AKRO N/A
- VEON N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- VEON Telecommunications Equipment
- Sector
- AKRO Health Care
- VEON Telecommunications
- Exchange
- AKRO Nasdaq
- VEON Nasdaq
- Market Cap
- AKRO 3.7B
- VEON 3.6B
- IPO Year
- AKRO 2019
- VEON 1996
- Fundamental
- Price
- AKRO $54.00
- VEON $47.86
- Analyst Decision
- AKRO Buy
- VEON Strong Buy
- Analyst Count
- AKRO 10
- VEON 4
- Target Price
- AKRO $73.56
- VEON $73.25
- AVG Volume (30 Days)
- AKRO 4.1M
- VEON 93.4K
- Earning Date
- AKRO 11-07-2025
- VEON 11-10-2025
- Dividend Yield
- AKRO N/A
- VEON N/A
- EPS Growth
- AKRO N/A
- VEON N/A
- EPS
- AKRO N/A
- VEON 13.63
- Revenue
- AKRO N/A
- VEON $4,148,000,000.00
- Revenue This Year
- AKRO N/A
- VEON $10.39
- Revenue Next Year
- AKRO N/A
- VEON $7.53
- P/E Ratio
- AKRO N/A
- VEON $3.63
- Revenue Growth
- AKRO N/A
- VEON 7.27
- 52 Week Low
- AKRO $21.34
- VEON $29.80
- 52 Week High
- AKRO $58.40
- VEON $64.00
- Technical
- Relative Strength Index (RSI)
- AKRO 68.71
- VEON 41.49
- Support Level
- AKRO $53.40
- VEON $49.91
- Resistance Level
- AKRO $54.05
- VEON $55.43
- Average True Range (ATR)
- AKRO 0.26
- VEON 1.79
- MACD
- AKRO -0.03
- VEON -0.13
- Stochastic Oscillator
- AKRO 72.46
- VEON 4.17
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About VEON VEON Ltd. ADS
VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan.